Formation Bio, which uses AI to co-develops drugs with biotech and pharma companies, raised a $372M Series D led by a16z, bringing its total funding to $528M — Formation Bio, a startup focused on applying AI to drug discovery with backing from OpenAI CEO Sam Altman, has raised …
Posted from: this blog via Microsoft Power Automate.